Free Trial
NASDAQ:OCEAW

Ocean Biomedical (OCEAW) Stock Price, News & Analysis

$0.0026 -0.01 (-71.11%)
As of 04/28/2025 10:09 AM Eastern

About Ocean Biomedical Stock (NASDAQ:OCEAW)

Key Stats

Today's Range
$0.0026
$0.0199
50-Day Range
$0.00
$0.03
52-Week Range
$0.00
$0.18
Volume
8,279 shs
Average Volume
45,811 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. It is also developing three product candidates based on the WPDS platform, including a malaria vaccine candidate; a humanized mAb malaria therapeutic candidate targeting Plasmodium falciparum glutamic-acid-rich protein (PfGARP); and a small molecule malaria therapeutic candidate targeting PfGARP, as well as a product candidate for the treatment of COVID-19 in hospitalized patients. The company was incorporated in 2019 and is based in Providence, Rhode Island. Ocean Biomedical, Inc. operates as a subsidiary of Poseidon Bio, LLC.

Receive OCEAW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ocean Biomedical and its competitors with MarketBeat's FREE daily newsletter.

OCEAW Stock News Headlines

Ocean Biomedical expands into energy, digital asset sectors
Trump’s Secret Weapon
Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.
Ocean Biomedical Delays Yearly Report Filing
See More Headlines

OCEAW Stock Analysis - Frequently Asked Questions

Ocean Biomedical's stock was trading at $0.0232 at the beginning of 2025. Since then, OCEAW stock has decreased by 88.8% and is now trading at $0.0026.
View the best growth stocks for 2025 here
.

Shares of OCEAW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:OCEAW
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:OCEAW) was last updated on 4/29/2025 by MarketBeat.com Staff
From Our Partners